Polycythemia vera

Results: 62



#Item
1Myelofibrosis / Janus kinase inhibitor / Splenomegaly / Myeloproliferative neoplasm / Ruxolitinib / Medical diagnosis / Polycythemia vera

HAEMATOLOGY AUDIT TEMPLATE

Add to Reading List

Source URL: www.bcshguidelines.com

Language: English - Date: 2015-09-20 08:20:56
2NOMINATION FORM FOR MPN HEROES  NOMINATION FORM FOR MPN HEROES

NOMINATION FORM FOR MPN HEROES NOMINATION FORM FOR MPN HEROES

Add to Reading List

Source URL: curemagazine.s3.amazonaws.com

Language: English - Date: 2015-07-10 15:12:35
3treatment of polycythemia vera with gleevec. gleevec and pha. gleevec on dr oz, gleevec researcher gleevec hydroxyurea factiva gleevec to treat metastatic melanoma cml gleevec molecular remission survival. free gleevec n

treatment of polycythemia vera with gleevec. gleevec and pha. gleevec on dr oz, gleevec researcher gleevec hydroxyurea factiva gleevec to treat metastatic melanoma cml gleevec molecular remission survival. free gleevec n

Add to Reading List

Source URL: www.naturaldiamondcompany.com

Language: English - Date: 2016-06-16 14:57:31
    4Molecular Diagnosis of Myeloid Neoplasias and Solid Tumors First report of mutations detected in the gene for NF-E2 Technology Myeloproliferative Neoplasms (MPN) are a group of several distinct, but clinically related ma

    Molecular Diagnosis of Myeloid Neoplasias and Solid Tumors First report of mutations detected in the gene for NF-E2 Technology Myeloproliferative Neoplasms (MPN) are a group of several distinct, but clinically related ma

    Add to Reading List

    Source URL: www.campus-technologies.de

    Language: English - Date: 2015-02-19 09:31:03
    5Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca

    Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca

    Add to Reading List

    Source URL: www.novartis.ca

    Language: English - Date: 2015-05-13 10:22:06
    6Phase 2 Trial of PRM-151, an Anti-Fibrotic Agent, in Patients with Myelofibrosis: Stage 1 Results S. Verstovsek1, R. Mesa2, L. Foltz3, V. Gupta4, J. Mascarenhas5, E. Ritchie6, R. Hoffman5, R. Silver6, W. J. Hong8, M. Kre

    Phase 2 Trial of PRM-151, an Anti-Fibrotic Agent, in Patients with Myelofibrosis: Stage 1 Results S. Verstovsek1, R. Mesa2, L. Foltz3, V. Gupta4, J. Mascarenhas5, E. Ritchie6, R. Hoffman5, R. Silver6, W. J. Hong8, M. Kre

    Add to Reading List

    Source URL: www.promedior.com

    Language: English - Date: 2014-06-13 01:07:42
    7___________________ CONTRAINDICATIONS ___________________  HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JAKAFI safely and effectively. See full prescribing infor

    ___________________ CONTRAINDICATIONS ___________________ HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JAKAFI safely and effectively. See full prescribing infor

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2014-12-04 17:30:23
    8

    PDF Document

    Add to Reading List

    Source URL: www.pbs.gov.au

    Language: English - Date: 2014-10-01 21:56:24
    9Microsoft Word - Fact Sheet - Updated and expanded MPN cluster investigation in northeastern Pennsylvania

    Microsoft Word - Fact Sheet - Updated and expanded MPN cluster investigation in northeastern Pennsylvania

    Add to Reading List

    Source URL: www.atsdr.cdc.gov

    Language: English - Date: 2015-03-19 12:50:23
    10Original Article Updated and Expanded Study of Polycythemia Vera   and Other Myeloproliferative Neoplasms

    Original Article Updated and Expanded Study of Polycythemia Vera and Other Myeloproliferative Neoplasms

    Add to Reading List

    Source URL: www.atsdr.cdc.gov

    Language: English - Date: 2015-03-19 12:50:24